274 related articles for article (PubMed ID: 26421409)
1. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
[TBL] [Abstract][Full Text] [Related]
2. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
4. The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome.
Fierro JJ; Velásquez-Berrío M; Ospina A; Henning S; de Leeuw K; Cadavid J ÁP
Rheumatol Int; 2024 Feb; 44(2):223-234. PubMed ID: 37741812
[TBL] [Abstract][Full Text] [Related]
5. Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
; Silver R; Craigo S; Porter F; Osmundson SS; Kuller JA; Norton ME
Am J Obstet Gynecol; 2023 Mar; 228(3):B41-B60. PubMed ID: 36084704
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and Antiphospholipid Syndrome.
Schreiber K; Hunt BJ
Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
[TBL] [Abstract][Full Text] [Related]
7. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Hooper A; Bacal V; Bedaiwy MA
Am J Reprod Immunol; 2023 Sep; 90(3):e13761. PubMed ID: 37641373
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis.
Frishman M; Radin M; Schreiber K
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):351-358. PubMed ID: 32675702
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
Broder A; Putterman C
J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
[TBL] [Abstract][Full Text] [Related]
10. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
11. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
[TBL] [Abstract][Full Text] [Related]
12. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni PL
J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
Belizna C
Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Latino JO; Udry S; Aranda F; Wingeyer SP; Romero DSF; Belizna C; Larrañaga G
Lupus; 2020 Nov; 29(13):1736-1742. PubMed ID: 32838621
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Li X; Shopit A; Wang J
Arch Gynecol Obstet; 2021 Nov; 304(5):1153-1160. PubMed ID: 34390384
[TBL] [Abstract][Full Text] [Related]
16. EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG; Andreoli L; Limper M; Amoura Z; Cervera R; Costedoat-Chalumeau N; Cuadrado MJ; Dörner T; Ferrer-Oliveras R; Hambly K; Khamashta MA; King J; Marchiori F; Meroni PL; Mosca M; Pengo V; Raio L; Ruiz-Irastorza G; Shoenfeld Y; Stojanovich L; Svenungsson E; Wahl D; Tincani A; Ward MM
Ann Rheum Dis; 2019 Oct; 78(10):1296-1304. PubMed ID: 31092409
[TBL] [Abstract][Full Text] [Related]
17. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
[TBL] [Abstract][Full Text] [Related]
18. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
[TBL] [Abstract][Full Text] [Related]
19. Current insights in obstetric antiphospholipid syndrome.
Schreiber K; Radin M; Sciascia S
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
[TBL] [Abstract][Full Text] [Related]
20. Serological evolution in women with positive antiphospholipid antibodies.
Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
